This report provides an analysis of the Global Immunology Biosimilars industry in terms of market segmentation By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.
The Global Immunology Biosimilars market showcased growth at a CAGR of 17.92% during 2020-2023. The market was valued at USD 8.03 billion in 2023 which is expected to reach USD 16.22 billion in 2030.
The global Immunology Biosimilars market is expected to witness strong growth during the forecast period, driven by multiple factors. A key factor is the rising incidence of chronic immunological conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, which is fueling the demand for cost-effective treatment solutions. As affordable alternatives to branded biologics, biosimilars are gaining significant traction, especially in regions with well-established healthcare systems and expanding patient populations.
Another major growth driver is the expiration of patents on blockbuster biologic drugs, opening the door for biosimilars to enter the market. This trend is particularly evident in developed markets like Europe and the Americas, where governments are promoting the use of biosimilars through favorable regulatory policies aimed at lowering healthcare costs.
In addition, the expansion of healthcare infrastructure in emerging markets, notably in the Asia Pacific region, is facilitating wider access to advanced therapies, boosting the demand for immunology biosimilars. Rising awareness of biosimilars and government-led initiatives are also expected to further stimulate market growth.
Moreover, leading industry players are increasingly focusing on strategic partnerships and ramping up investments in research and development to enhance their product offerings and expand their market reach, driving the market’s continued expansion.
The Global Immunology Biosimilars market showcased growth at a CAGR of 17.92% during 2020-2023. The market was valued at USD 8.03 billion in 2023 which is expected to reach USD 16.22 billion in 2030.
The global Immunology Biosimilars market is expected to witness strong growth during the forecast period, driven by multiple factors. A key factor is the rising incidence of chronic immunological conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, which is fueling the demand for cost-effective treatment solutions. As affordable alternatives to branded biologics, biosimilars are gaining significant traction, especially in regions with well-established healthcare systems and expanding patient populations.
Another major growth driver is the expiration of patents on blockbuster biologic drugs, opening the door for biosimilars to enter the market. This trend is particularly evident in developed markets like Europe and the Americas, where governments are promoting the use of biosimilars through favorable regulatory policies aimed at lowering healthcare costs.
In addition, the expansion of healthcare infrastructure in emerging markets, notably in the Asia Pacific region, is facilitating wider access to advanced therapies, boosting the demand for immunology biosimilars. Rising awareness of biosimilars and government-led initiatives are also expected to further stimulate market growth.
Moreover, leading industry players are increasingly focusing on strategic partnerships and ramping up investments in research and development to enhance their product offerings and expand their market reach, driving the market’s continued expansion.
Scope of the Report
- The report analyses the Immunology Biosimilars Market by Value ( USD Million).
- The report analyses the Immunology Biosimilars Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
- The report presents the analysis of Immunology Biosimilars Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
- The report analyses the Immunology Biosimilars Market By Indication (Arthritis, Irritable Bowel Disease, Other Indications)
- The report analyses the Immunology Biosimilars Market By Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies).
- The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Indication, By Route of Administration and By Distribution Channel.
- Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include F. Hoffmann-La Roche AG, Merck & Co., Inc., Eli Lily & Co., Pfizer, Novartis AG, Teva Pharmaceutical, Boehringer Ingelheim, Celltrion Inc, Samsungbioepis Co,.Ltd, Amgen Inc.
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Focus on Complex Biosimilars
2.2 Leverage Digital Health
2.2 Leverage Digital Health
3. Global Immunology Biosimilars Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Immunology Biosimilars Market
3.2 Overview of biosimilar development compared with a reference medicine
3.3 EU biosimilar landscape of approvals (marketing authorizations)
3.4 Global Immunology Biosimilars Market: Dashboard
3.5 Global Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.6 Global Immunology Biosimilars Market: Market Value Assessment
3.7 Global Immunology Biosimilars Market Segmentation: By Indication
3.7.1 Global Immunology Biosimilars Market, By Indication Overview
3.7.2 Global Immunology Biosimilars Market Attractiveness Index, By Indication
3.7.3 Global Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Immunology Biosimilars Market Segmentation: By Distribution Channel
3.8.1 Global Immunology Biosimilars Market, By Distribution Channel Overview
3.8.2 Global Immunology Biosimilars Market Attractiveness Index, By Distribution Channel
3.8.3 Global Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.2 Overview of biosimilar development compared with a reference medicine
3.3 EU biosimilar landscape of approvals (marketing authorizations)
3.4 Global Immunology Biosimilars Market: Dashboard
3.5 Global Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.6 Global Immunology Biosimilars Market: Market Value Assessment
3.7 Global Immunology Biosimilars Market Segmentation: By Indication
3.7.1 Global Immunology Biosimilars Market, By Indication Overview
3.7.2 Global Immunology Biosimilars Market Attractiveness Index, By Indication
3.7.3 Global Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Immunology Biosimilars Market Segmentation: By Distribution Channel
3.8.1 Global Immunology Biosimilars Market, By Distribution Channel Overview
3.8.2 Global Immunology Biosimilars Market Attractiveness Index, By Distribution Channel
3.8.3 Global Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
4. Immunology Biosimilars Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
4.2 Regional Snapshot
5. Americas Immunology Biosimilars Market: Historic and Forecast
5.1 Americas Immunology Biosimilars Market: Snapshot
5.2 Americas Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Immunology Biosimilars Market: Key Factors
5.4 Americas Immunology Biosimilars Market: Segment Analysis
5.5 Americas Immunology Biosimilars Market Segmentation: By Indication
5.5.1 Americas Immunology Biosimilars Market, By Indication Overview
5.5.2 Americas Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Immunology Biosimilars Market Segmentation: By Distribution Channel
5.6.1 Americas Immunology Biosimilars Market, By Distribution Channel Overview
5.6.2 Americas Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Immunology Biosimilars Market Segmentation: By Country
5.7.1 Americas Immunology Biosimilars Market, by Country Overview
5.7.2 United States Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.2.1 United States Immunology Biosimilars Market, By Indication
5.7.2.2 United States Immunology Biosimilars Market, By Distribution Channel
5.7.3 Canada Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.3.1 Canada Immunology Biosimilars Market, By Indication
5.7.3.2 Canada Immunology Biosimilars Market, By Distribution Channel
5.7.4 Rest of Americas Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.5.1 Rest of Americas Immunology Biosimilars Market, By Indication
5.7.5.2 Rest of Americas Immunology Biosimilars Market, By Distribution Channel
5.2 Americas Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Immunology Biosimilars Market: Key Factors
5.4 Americas Immunology Biosimilars Market: Segment Analysis
5.5 Americas Immunology Biosimilars Market Segmentation: By Indication
5.5.1 Americas Immunology Biosimilars Market, By Indication Overview
5.5.2 Americas Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Immunology Biosimilars Market Segmentation: By Distribution Channel
5.6.1 Americas Immunology Biosimilars Market, By Distribution Channel Overview
5.6.2 Americas Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Immunology Biosimilars Market Segmentation: By Country
5.7.1 Americas Immunology Biosimilars Market, by Country Overview
5.7.2 United States Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.2.1 United States Immunology Biosimilars Market, By Indication
5.7.2.2 United States Immunology Biosimilars Market, By Distribution Channel
5.7.3 Canada Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.3.1 Canada Immunology Biosimilars Market, By Indication
5.7.3.2 Canada Immunology Biosimilars Market, By Distribution Channel
5.7.4 Rest of Americas Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.5.1 Rest of Americas Immunology Biosimilars Market, By Indication
5.7.5.2 Rest of Americas Immunology Biosimilars Market, By Distribution Channel
6. Europe Immunology Biosimilars Market: Historic and Forecast
6.1 Europe Immunology Biosimilars Market: Snapshot
6.2 Europe Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Immunology Biosimilars Market: Key Factors
6.4 Europe Immunology Biosimilars Market: Segment Analysis
6.5 Europe Immunology Biosimilars Market Segmentation: By Indication
6.5.1 Europe Immunology Biosimilars Market, By Indication Overview
6.5.2 Europe Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Immunology Biosimilars Market Segmentation: By Distribution Channel
6.6.1 Europe Immunology Biosimilars Market, By Distribution Channel Overview
6.6.2 Europe Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Immunology Biosimilars Market Segmentation: By Country
6.7.1 Europe Immunology Biosimilars Market, by Country Overview
6.7.2 United Kingdom Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.2.1 United Kingdom Immunology Biosimilars Market, By Indication
6.7.2.2 United Kingdom Immunology Biosimilars Market, By Distribution Channel
6.7.3 Germany Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.3.1 Germany Immunology Biosimilars Market, By Indication
6.7.3.2 Germany Immunology Biosimilars Market, By Distribution Channel
6.7.4 France Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.4.1 France Immunology Biosimilars Market, By Indication
6.7.4.2 France Immunology Biosimilars Market, By Distribution Channel
6.7.5 Italy Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.5.1 Italy Immunology Biosimilars Market, By Indication
6.7.5.2 Italy Immunology Biosimilars Market, By Distribution Channel
6.7.6 Spain Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.6.1 Spain Immunology Biosimilars Market, By Indication
6.7.6.2 Spain Immunology Biosimilars Market, By Distribution Channel
6.7.6 Rest of Europe Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.6.1 Rest of Europe Immunology Biosimilars Market, By Indication
6.7.6.2 Rest of Europe Immunology Biosimilars Market, By Distribution Channel
6.2 Europe Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Immunology Biosimilars Market: Key Factors
6.4 Europe Immunology Biosimilars Market: Segment Analysis
6.5 Europe Immunology Biosimilars Market Segmentation: By Indication
6.5.1 Europe Immunology Biosimilars Market, By Indication Overview
6.5.2 Europe Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Immunology Biosimilars Market Segmentation: By Distribution Channel
6.6.1 Europe Immunology Biosimilars Market, By Distribution Channel Overview
6.6.2 Europe Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Immunology Biosimilars Market Segmentation: By Country
6.7.1 Europe Immunology Biosimilars Market, by Country Overview
6.7.2 United Kingdom Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.2.1 United Kingdom Immunology Biosimilars Market, By Indication
6.7.2.2 United Kingdom Immunology Biosimilars Market, By Distribution Channel
6.7.3 Germany Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.3.1 Germany Immunology Biosimilars Market, By Indication
6.7.3.2 Germany Immunology Biosimilars Market, By Distribution Channel
6.7.4 France Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.4.1 France Immunology Biosimilars Market, By Indication
6.7.4.2 France Immunology Biosimilars Market, By Distribution Channel
6.7.5 Italy Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.5.1 Italy Immunology Biosimilars Market, By Indication
6.7.5.2 Italy Immunology Biosimilars Market, By Distribution Channel
6.7.6 Spain Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.6.1 Spain Immunology Biosimilars Market, By Indication
6.7.6.2 Spain Immunology Biosimilars Market, By Distribution Channel
6.7.6 Rest of Europe Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.6.1 Rest of Europe Immunology Biosimilars Market, By Indication
6.7.6.2 Rest of Europe Immunology Biosimilars Market, By Distribution Channel
7. Asia Pacific Immunology Biosimilars Market: Historic and Forecast
7.1 Asia Pacific Immunology Biosimilars Market: Snapshot
7.2 Asia Pacific Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Immunology Biosimilars Market: Key Factors
7.4 Asia Pacific Immunology Biosimilars Market: Segment Analysis
7.5 Asia Pacific Immunology Biosimilars Market Segmentation: By Indication
7.5.1 Asia Pacific Immunology Biosimilars Market, By Indication Overview
7.5.2 Asia Pacific Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Immunology Biosimilars Market Segmentation: By Distribution Channel
7.6.1 Asia Pacific Immunology Biosimilars Market, By Distribution Channel Overview
7.6.2 Asia Pacific Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Immunology Biosimilars Market Segmentation: By Country
7.7.1 Asia Pacific Immunology Biosimilars Market, by Country Overview
7.7.2 China Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.2.1 China Immunology Biosimilars Market, By Indication
7.7.2.2 China Immunology Biosimilars Market, By Distribution Channel
7.7.3 Japan Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.3.1 Japan Immunology Biosimilars Market, By Indication
7.7.3.2 Japan Immunology Biosimilars Market, By Distribution Channel
7.7.4 India Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.4.1 India Immunology Biosimilars Market, By Indication
7.7.4.2 India Immunology Biosimilars Market, By Distribution Channel
7.7.5 Rest of Asia Pacific Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.5.1 Rest of Asia Pacific Immunology Biosimilars Market, By Indication
7.7.5.2 Rest of Asia Pacific Immunology Biosimilars Market, By Distribution Channel
7.2 Asia Pacific Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Immunology Biosimilars Market: Key Factors
7.4 Asia Pacific Immunology Biosimilars Market: Segment Analysis
7.5 Asia Pacific Immunology Biosimilars Market Segmentation: By Indication
7.5.1 Asia Pacific Immunology Biosimilars Market, By Indication Overview
7.5.2 Asia Pacific Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Immunology Biosimilars Market Segmentation: By Distribution Channel
7.6.1 Asia Pacific Immunology Biosimilars Market, By Distribution Channel Overview
7.6.2 Asia Pacific Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Immunology Biosimilars Market Segmentation: By Country
7.7.1 Asia Pacific Immunology Biosimilars Market, by Country Overview
7.7.2 China Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.2.1 China Immunology Biosimilars Market, By Indication
7.7.2.2 China Immunology Biosimilars Market, By Distribution Channel
7.7.3 Japan Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.3.1 Japan Immunology Biosimilars Market, By Indication
7.7.3.2 Japan Immunology Biosimilars Market, By Distribution Channel
7.7.4 India Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.4.1 India Immunology Biosimilars Market, By Indication
7.7.4.2 India Immunology Biosimilars Market, By Distribution Channel
7.7.5 Rest of Asia Pacific Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.5.1 Rest of Asia Pacific Immunology Biosimilars Market, By Indication
7.7.5.2 Rest of Asia Pacific Immunology Biosimilars Market, By Distribution Channel
8. Middle East & Africa Immunology Biosimilars Market: Historic and Forecast
8.1 Middle East & Africa Immunology Biosimilars Market: Snapshot
8.2 Middle East & Africa Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Immunology Biosimilars Market: Key Factors
8.4 Middle East and Africa Immunology Biosimilars Market: Segment Analysis
8.5 Middle East & Africa Immunology Biosimilars Market Segmentation: By Indication
8.5.1 Middle East & Africa Immunology Biosimilars Market, By Indication Overview
8.5.2 Middle East & Africa Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Immunology Biosimilars Market Segmentation: By Distribution Channel
8.6.1 Middle East & Africa Immunology Biosimilars Market, By Distribution Channel Overview
8.6.2 Middle East & Africa Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.2 Middle East & Africa Immunology Biosimilars Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Immunology Biosimilars Market: Key Factors
8.4 Middle East and Africa Immunology Biosimilars Market: Segment Analysis
8.5 Middle East & Africa Immunology Biosimilars Market Segmentation: By Indication
8.5.1 Middle East & Africa Immunology Biosimilars Market, By Indication Overview
8.5.2 Middle East & Africa Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Immunology Biosimilars Market Segmentation: By Distribution Channel
8.6.1 Middle East & Africa Immunology Biosimilars Market, By Distribution Channel Overview
8.6.2 Middle East & Africa Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Immunology Biosimilars Market
9.2 Drivers
9.3 Restraints
9.4 Trends
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Immunology Biosimilars Market
11.4 Company Profiles
11.4.1 F. Hoffmann-La Roche AG
11.4.2 Merck & Co., Inc.
11.4.3 Eli Lily & Co.
11.4.4 Pfizer
11.4.5 Novartis AG
11.4.6 Teva Pharmaceutical
11.4.7 Boehringer Ingelheim
11.4.8 Celltrion Inc
11.4.9 Samsungbioepis Co,.Ltd
11.4.10 Amgen Inc.
11.2 Market Position Matrix
11.3 Market Share Analysis of Immunology Biosimilars Market
11.4 Company Profiles
11.4.1 F. Hoffmann-La Roche AG
11.4.2 Merck & Co., Inc.
11.4.3 Eli Lily & Co.
11.4.4 Pfizer
11.4.5 Novartis AG
11.4.6 Teva Pharmaceutical
11.4.7 Boehringer Ingelheim
11.4.8 Celltrion Inc
11.4.9 Samsungbioepis Co,.Ltd
11.4.10 Amgen Inc.
List of Figures
Figure 1: Global Immunology Biosimilars Market Size, By Value, 2020-2023 (USD Million)
Figure 2: Global Immunology Biosimilars Market Size, By Value, 2024-2030 (USD Million)
Figure 3: Global Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 4: Market Attractiveness Analysis of Global Immunology Biosimilars Market, By Indication (2024-2030)
Figure 5: Global Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 6: Global Immunology Biosimilars Market Absolute Opportunity, By Arthritis, 2020-2030 (USD Million)
Figure 7: Global Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 8: Global Immunology Biosimilars Market Absolute Opportunity, By Irritable Bowel Disease, 2020-2030 (USD Million)
Figure 9: Global Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 10: Global Immunology Biosimilars Market Absolute Opportunity, By Other Indications, 2020-2030 (USD Million)
Figure 11: Market Attractiveness Analysis of Global Immunology Biosimilars Market, By Distribution Channel (2024-2030)
Figure 12: Global Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 13: Global Immunology Biosimilars Market Absolute Opportunity, By Hospital Pharmacies, 2020-2030 (USD Million)
Figure 14: Global Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 15: Global Immunology Biosimilars Market Absolute Opportunity, By Retail & Online Pharmacies, 2020-2030 (USD Million)
Figure 16: Americas Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 17: Americas Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 18: Americas Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 19: Americas Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 20: Americas Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 21: Americas Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 22: Americas Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 23: United States Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 24: United States Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 25: United States Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 26: United States Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 27: Canada Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 28: Canada Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 29: Canada Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 30: Canada Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 31: Rest of Americas Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 32: Rest of Americas Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 33: Rest of Americas Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 34: Rest of Americas Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 35: Europe Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 36: Europe Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 37: Europe Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 38: Europe Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 39: Europe Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 40: Europe Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 41: Europe Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: United Kingdom Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 43: United Kingdom Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 44: United Kingdom Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 45: United Kingdom Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 46: Germany Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 47: Germany Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 48: Germany Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 49: Germany Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 50: France Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 51: France Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 52: France Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 53: France Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 54: Italy Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 55: Italy Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 56: Italy Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 57: Italy Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 58: Spain Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 59: Spain Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 60: Spain Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 61: Spain Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 62: Rest of Europe Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 63: Rest of Europe Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 64: Rest of Europe Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 65: Rest of Europe Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 66: Asia Pacific Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 67: Asia Pacific Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 68: Asia Pacific Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 69: Asia Pacific Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 70: Asia Pacific Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 71: Asia Pacific Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 72: Asia Pacific Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 73: China Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 74: China Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 75: China Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 76: China Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 77: Japan Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 78: Japan Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 79: Japan Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 80: Japan Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 81: India Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 82: India Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 83: India Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 84: India Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 85: Rest of Asia Pacific Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 86: Rest of Asia Pacific Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 87: Rest of Asia Pacific Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 88: Rest of Asia Pacific Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 89: Middle East and Africa Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 90: Middle East and Africa Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 91: Middle East and Africa Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Middle East and Africa Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Middle East and Africa Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 94: Middle East and Africa Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 95: Middle East and Africa Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 96: Market Share of Prominent Companies of Immunology Biosimilars Market, 2023 (%)
Figure 97: Roche Revenues, 2021-2023 (USD Million)
Figure 98: Roche Revenue , By Sales Division, 2023 (%)
Figure 99: Roche Revenue , By Geographical Segment, 2023 (%)
Figure 100: Merck & Co., Inc. Revenues, 2021-2023 (USD Million)
Figure 101: Merck & Co., Inc. Revenues, By Geographic Segments, 2023 (%)
Figure 102: Merck & Co., Inc. Revenue , By Business Segments, 2023 (%)
Figure 103: Eli Lily & Co. Revenues, 2021-2023 (USD Million)
Figure 104: Eli Lily & Co. Revenues, By Geographic Segments, 2023 (%)
Figure 105: Eli Lily & Co. Revenue , By Business Segments, 2023 (%)
Figure 106: Pfizer Revenues, 2021-2023 (USD Million)
Figure 107: Pfizer Revenues, By Business Segments, 2023 (%)
Figure 108: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
Figure 109: Novartis Revenues, 2021-2023 (USD Million)
Figure 110: Novartis Revenues, By Geographic Segments, 2023 (%)
Figure 111: Novartis Revenue , By Business Segments, 2023 (%)
Figure 112: Teva Pharmaceuticals Revenues, 2021-2023 (USD Million)
Figure 113: Teva Pharmaceuticals Revenue , By Geographical Segments, 2023 (%)
Figure 114: Celltrion Inc Revenues, 2021-2023 (USD Billion)
Figure 115: Celltrion Inc Revenues, By Geographic Segments, 2023 (%)
Figure 116: Samsungbioepis Revenues, 2021-2023 (USD Billion)
Figure 117: Samsungbioepis Revenues, By Business Segments, 2023 (%)
Figure 118: Amgen Revenues, 2021-2023 (USD Million)
Figure 119: Amgen Revenues, By Geographic Segments, 2023 (%)
Figure 120: Amgen Revenue , By Business Segments, 2023 (%)
Figure 2: Global Immunology Biosimilars Market Size, By Value, 2024-2030 (USD Million)
Figure 3: Global Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 4: Market Attractiveness Analysis of Global Immunology Biosimilars Market, By Indication (2024-2030)
Figure 5: Global Immunology Biosimilars Market Size, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 6: Global Immunology Biosimilars Market Absolute Opportunity, By Arthritis, 2020-2030 (USD Million)
Figure 7: Global Immunology Biosimilars Market Size, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 8: Global Immunology Biosimilars Market Absolute Opportunity, By Irritable Bowel Disease, 2020-2030 (USD Million)
Figure 9: Global Immunology Biosimilars Market Size, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 10: Global Immunology Biosimilars Market Absolute Opportunity, By Other Indications, 2020-2030 (USD Million)
Figure 11: Market Attractiveness Analysis of Global Immunology Biosimilars Market, By Distribution Channel (2024-2030)
Figure 12: Global Immunology Biosimilars Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 13: Global Immunology Biosimilars Market Absolute Opportunity, By Hospital Pharmacies, 2020-2030 (USD Million)
Figure 14: Global Immunology Biosimilars Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 15: Global Immunology Biosimilars Market Absolute Opportunity, By Retail & Online Pharmacies, 2020-2030 (USD Million)
Figure 16: Americas Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 17: Americas Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 18: Americas Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 19: Americas Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 20: Americas Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 21: Americas Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 22: Americas Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 23: United States Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 24: United States Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 25: United States Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 26: United States Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 27: Canada Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 28: Canada Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 29: Canada Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 30: Canada Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 31: Rest of Americas Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 32: Rest of Americas Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 33: Rest of Americas Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 34: Rest of Americas Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 35: Europe Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 36: Europe Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 37: Europe Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 38: Europe Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 39: Europe Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 40: Europe Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 41: Europe Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: United Kingdom Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 43: United Kingdom Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 44: United Kingdom Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 45: United Kingdom Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 46: Germany Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 47: Germany Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 48: Germany Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 49: Germany Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 50: France Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 51: France Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 52: France Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 53: France Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 54: Italy Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 55: Italy Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 56: Italy Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 57: Italy Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 58: Spain Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 59: Spain Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 60: Spain Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 61: Spain Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 62: Rest of Europe Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 63: Rest of Europe Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 64: Rest of Europe Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 65: Rest of Europe Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 66: Asia Pacific Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 67: Asia Pacific Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 68: Asia Pacific Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 69: Asia Pacific Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 70: Asia Pacific Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 71: Asia Pacific Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 72: Asia Pacific Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 73: China Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 74: China Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 75: China Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 76: China Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 77: Japan Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 78: Japan Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 79: Japan Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 80: Japan Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 81: India Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 82: India Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 83: India Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 84: India Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 85: Rest of Asia Pacific Immunology Biosimilars Market, By Value, 2020-2030 (USD Millions & CAGR)
Figure 86: Rest of Asia Pacific Immunology Biosimilars Market Value, By Distribution Channel, 2023 (USD Million)
Figure 87: Rest of Asia Pacific Immunology Biosimilars Market Share, By Indication, By Value, 2023 (%)
Figure 88: Rest of Asia Pacific Immunology Biosimilars Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 89: Middle East and Africa Immunology Biosimilars Market Size, By Value, 2020H-2030F (USD Million)
Figure 90: Middle East and Africa Immunology Biosimilars Market Share, By Distribution Channel, 2023 (%)
Figure 91: Middle East and Africa Immunology Biosimilars Market, By Arthritis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Middle East and Africa Immunology Biosimilars Market, By Irritable Bowel Disease, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Middle East and Africa Immunology Biosimilars Market, By Other Indications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 94: Middle East and Africa Immunology Biosimilars Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 95: Middle East and Africa Immunology Biosimilars Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 96: Market Share of Prominent Companies of Immunology Biosimilars Market, 2023 (%)
Figure 97: Roche Revenues, 2021-2023 (USD Million)
Figure 98: Roche Revenue , By Sales Division, 2023 (%)
Figure 99: Roche Revenue , By Geographical Segment, 2023 (%)
Figure 100: Merck & Co., Inc. Revenues, 2021-2023 (USD Million)
Figure 101: Merck & Co., Inc. Revenues, By Geographic Segments, 2023 (%)
Figure 102: Merck & Co., Inc. Revenue , By Business Segments, 2023 (%)
Figure 103: Eli Lily & Co. Revenues, 2021-2023 (USD Million)
Figure 104: Eli Lily & Co. Revenues, By Geographic Segments, 2023 (%)
Figure 105: Eli Lily & Co. Revenue , By Business Segments, 2023 (%)
Figure 106: Pfizer Revenues, 2021-2023 (USD Million)
Figure 107: Pfizer Revenues, By Business Segments, 2023 (%)
Figure 108: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
Figure 109: Novartis Revenues, 2021-2023 (USD Million)
Figure 110: Novartis Revenues, By Geographic Segments, 2023 (%)
Figure 111: Novartis Revenue , By Business Segments, 2023 (%)
Figure 112: Teva Pharmaceuticals Revenues, 2021-2023 (USD Million)
Figure 113: Teva Pharmaceuticals Revenue , By Geographical Segments, 2023 (%)
Figure 114: Celltrion Inc Revenues, 2021-2023 (USD Billion)
Figure 115: Celltrion Inc Revenues, By Geographic Segments, 2023 (%)
Figure 116: Samsungbioepis Revenues, 2021-2023 (USD Billion)
Figure 117: Samsungbioepis Revenues, By Business Segments, 2023 (%)
Figure 118: Amgen Revenues, 2021-2023 (USD Million)
Figure 119: Amgen Revenues, By Geographic Segments, 2023 (%)
Figure 120: Amgen Revenue , By Business Segments, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: Overview of biosimilar development compared with a reference medicine
Table A3: EU biosimilar landscape of approvals (marketing authorizations)
Table A4: United States Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A5: United States Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A6: United States Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A7: United States Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A8: Canada Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A9: Canada Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A10: Canada Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A11: Canada Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A12: Rest of Americas Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A13: Rest of Americas Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A14: Rest of Americas Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A15: Rest of Americas Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A16: United Kingdom Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A17: United Kingdom Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A18: United Kingdom Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A19: United Kingdom Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A20: Germany Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A21: Germany Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A22: Germany Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A23: Germany Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A24: France Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A25: France Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A26: France Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A27: France Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A28: Italy Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A29: Italy Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A30: Italy Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A31: Italy Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A32: Spain Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A33: Spain Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A34: Spain Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A35: Spain Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A36: Rest of Europe Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A37: Rest of Europe Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A38: Rest of Europe Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A39: Rest of Europe Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A40: China Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A41: China Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A42: China Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A43: China Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A44: Japan Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A45: Japan Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A46: Japan Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A47: Japan Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A48: India Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A49: India Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A50: India Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A51: India Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A52: Rest of Asia Pacific Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A53: Rest of Asia Pacific Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A54: Rest of Asia Pacific Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A55: Rest of Asia Pacific Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A56: Roche Key Financials, 2021-2023
Table A57: Merck & Co., Inc. Key Financials, 2021-2023
Table A58: Eli Lily & Co. Key Financials, 2021-2023
Table A59: Pfizer Key Financials, 2021-2023
Table A60: Novartis Key Financials, 2021-2023
Table A61: Teva Pharmaceuticals Key Financials, 2021-2023
Table A62: Celltrion Inc Key Financials, 2021-2023
Table A63: Amgen Key Financials, 2021-2023
Table A2: Overview of biosimilar development compared with a reference medicine
Table A3: EU biosimilar landscape of approvals (marketing authorizations)
Table A4: United States Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A5: United States Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A6: United States Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A7: United States Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A8: Canada Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A9: Canada Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A10: Canada Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A11: Canada Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A12: Rest of Americas Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A13: Rest of Americas Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A14: Rest of Americas Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A15: Rest of Americas Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A16: United Kingdom Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A17: United Kingdom Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A18: United Kingdom Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A19: United Kingdom Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A20: Germany Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A21: Germany Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A22: Germany Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A23: Germany Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A24: France Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A25: France Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A26: France Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A27: France Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A28: Italy Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A29: Italy Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A30: Italy Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A31: Italy Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A32: Spain Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A33: Spain Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A34: Spain Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A35: Spain Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A36: Rest of Europe Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A37: Rest of Europe Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A38: Rest of Europe Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A39: Rest of Europe Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A40: China Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A41: China Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A42: China Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A43: China Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A44: Japan Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A45: Japan Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A46: Japan Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A47: Japan Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A48: India Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A49: India Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A50: India Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A51: India Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A52: Rest of Asia Pacific Immunology Biosimilars Market, By Indication, By Value, 2020-2023 (USD Million)
Table A53: Rest of Asia Pacific Immunology Biosimilars Market, By Indication, By Value, 2024-2030 (USD Million)
Table A54: Rest of Asia Pacific Immunology Biosimilars Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A55: Rest of Asia Pacific Immunology Biosimilars Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A56: Roche Key Financials, 2021-2023
Table A57: Merck & Co., Inc. Key Financials, 2021-2023
Table A58: Eli Lily & Co. Key Financials, 2021-2023
Table A59: Pfizer Key Financials, 2021-2023
Table A60: Novartis Key Financials, 2021-2023
Table A61: Teva Pharmaceuticals Key Financials, 2021-2023
Table A62: Celltrion Inc Key Financials, 2021-2023
Table A63: Amgen Key Financials, 2021-2023
Companies Mentioned
- F. Hoffmann-La Roche AG
- Merck & Co., Inc.
- Eli Lily & Co.
- Pfizer
- Novartis AG
- Teva Pharmaceutical
- Boehringer Ingelheim
- Celltrion Inc
- Samsungbioepis Co,.Ltd
- Amgen Inc.
